SuperHapten: A comprehensive database for small immunogenic compounds

Nucleic Acids Research

Volumn 35, Issue SUPPL. 1, 2007, Pages

  Günther, Stefan ^a   Hempel, Dorothea ^a   Dunkel, Mathias ^a   Rother, Kristian ^a   Preissner, Robert ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HALOTHANE; HAPTEN; NAPHTHOL DERIVATIVE; PENICILLIN DERIVATIVE; PENICILLIN G; PESTICIDE; PHENOL DERIVATIVE; TARTRAZINE; WARFARIN;

ARTICLE; BIOINFORMATICS; CROSS REACTION; DRUG STRUCTURE; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; IMMUNOGENICITY; INFORMATION RETRIEVAL; INTERNET; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN STRUCTURE; SUPERHAPTEN;

CROSS REACTIONS; DATABASES, FACTUAL; HAPTENS; INTERNET; USER-COMPUTER INTERFACE;

EID: 33846063190     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkl849     Document Type: Article

References (33)

1. Rioux,J.D. and Abbas,A.K. (2005) Paths to understanding the genetic basis of autoimmune disease. Nature, 435, 584-589.
2. O'Neill,L.A. (2006) How Toll-like receptors signal: What we know and what we don't know. Curr. Opin. Immunol., 18, 3-9.
3. Mahoney,J.A. and Rosen,A. (2005) Apoptosis and autoimmunity. Curr. Opin. Immunol., 17, 583-588.
4. Linhart,B. and Valenta,R. (2005) Molecular design of allergy vaccines. Curr. Opin. Immunol., 17, 646-655.
5. Houghton,M. and Abrignani,S. (2005) Prospects for a vaccine against the hepatitis C virus. Nature, 436, 961-966.
6. Kim,S.I., Park,Y. and Hong,H.J. (2005) Antibody engineering for the development of therapeutic antibodies. Mol. Cells, 20, 17-29.
7. Singh,K.V., Kaur,J., Varshney,G.C., Raje,M. and Suri,C.R. (2004) Synthesis and characterization of hapten-protein conjugates for antibody production against small molecules. Bioconjug. Chem., 15, 168-173.
8. Cho,A.Y., Yi,K.S., Rhim,J.H., Kim,K.I., Park,J.Y., Keum,E.H., Chung,J. and Oh,S. (2006) Detection of abnormally high amygdalin content in food by an enzyme immunoassay. Mol. Cells, 21, 308-313.
9. Hanson,C.V., Nishiyama,Y. and Paul,S. (2005) Catalytic antibodies and their applications. Curr. Opin. Biotechnol., 16, 631-636.
10. Holzer,A.M., Kaplan,L.L. and Levis,W.R. (2006) Haptens as drugs: Contact allergens are powerful topical immunomodulators. J. Drugs Dermatol., 5, 410-416.
11. Berd,D., Sato,T., Maguire,H.C., Jr, Kairys,J. and Mastrangelo,M.J. (2004) Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccine. J. Clin. Oncol., 22, 403-415.
12. Divkovic,M., Pease,C.K., Gerberick,G.F. and Basketter,D.A. (2005) Hapten-protein binding: From theory to practical application in the in vitro prediction of skin sensitization. Contact Dermatitis, 53, 189-200.
13. Vanoirbeek,J.A., Tarkowski,M., Vanhooren,H.M., De Vooght,V., Nemery,B. and Hoet,P.H. (2006) Validation of a mouse model of chemical-induced asthma using trimellitic anhydride, a respiratory sensitizer, and dinitrochlorobenzene, a dermal sensitizer. J. Allergy. Clin. Immunol., 117, 1090-1097.
14. Ju,C. (2005) Immunological mechanisms of drug-induced liver injury. Curr. Opin. Drug. Discov. Devel., 8, 38-43.
15. Pelizza,L., De Luca,P., La Pesa,M. and Minervino,A. (2006) Drug-induced systemic lupus erythematosus after 7 years of treatment with carbamazepine. Acta. Biomed Ateneo Parmense, 77, 17-19.
16. Ju,C. and Pohl,L.R. (2005) Tolerogenic role of Kupffer cells in immune-mediated adverse drug reactions. Toxicology, 209, 109-112.
17. Lefranc,M.P. (2005) IMGT, the international ImMunoGeneTics information system(R): A standardized approach for immunogenetics and immunoinformatics. Immunome Res., 1, 3.
18. McSparron,H., Blythe,M.J., Zygouri,C., Doytchinova,I.A. and Flower,D.R. (2003) JenPep: A novel computational information resource for immunobiology and vaccinology. J. Chem. Inf. Comput. Sci., 43, 1276-1287.
19. Toseland,C.P., Clayton,D.J., McSparron,H., Hemsley,S.L., Blythe,M.J., Paine,K., Doytchinova,I.A., Guan,P., Hattotuwagama,C.K. and Flower,D.R. (2005) AntiJen: A quantitative immunology database integrating functional, thermodynamic, kinetic, biophysical, and cellular data. Immunome Res., 1, 4.
20. Schlessinger,A., Ofran,Y., Yachdav,G. and Rost,B. (2006) Epitome: database of structure-inferred antigenic epitopes. Nucleic Acids Res., 34, D777-D780.
21. Johnson,G. and Wu,T.T. (2000) Kabat database and its applications: 30 years after the first variability plot. Nucleic Acids Res., 28, 214-218.
22. Bhasin,M., Singh,H. and Raghava,G.P. (2003) MHCBN: A comprehensive database of MHC binding and non-binding peptides. Bioinformatics, 19, 665-666.
23. Saha,S., Bhasin,M. and Raghava,G.P. (2005) Bcipep: A database of B-cell epitopes. BMC Genomics, 6, 79.
24. Schonbach,C., Koh,J.L., Flower,D.R., Wong,L. and Brusic,V. (2002) FIMM, a database of functional molecular immunology: Update 2002. Nucleic Acids Res., 30, 226-229.
25. Sathiamurthy,M., Peters,B., Bui,H.H., Sidney,J., Mokili,J., Wilson,S.S., Fleri,W., McGuinness,D.L., Bourne,P.E. and Sette,A. (2005) An ontology for immune epitopes: Application to the design of a broad scope database of immune reactivities. Immunome Res., 1, 2.
26. Singh,M.K., Srivastava,S., Raghava,G.P. and Varshney,G.C. (2006) HaptenDB: A comprehensive database of haptens, carrier proteins and anti-hapten antibodies. Bioinformatics, 22, 253-255.
27. Pfaar,O. and Klimek,L. (2006) Aspirin desensitization in aspirin intolerance: Update on current standards and recent improvements. Curr. Opin. Allergy Clin. Immunol., 6, 161-166.
28. O'Brien,M. and Koo,J. (2006) The mechanism of lithium and beta-blocking agents in inducing and exacerbating psoriasis. J. Drugs Dermatol., 5, 426-432.
29. Martin,Y.C., Kofron,J.L. and Traphagen,L.M. (2002) Do structurally similar molecules have similar biological activity? J. Med. Chem., 45, 4350-4358.
30. Yamamoto,O. and Tokura,Y. (2003) Photocontact dermatitis and chloracne: two major occupational and environmental skin diseases induced by different actions of halogenated chemicals. J. Dermatol. Sci., 32, 85-94.
31. Delaney,J.S. (1996) Assessing the ability of chemical similarity measures to discriminate between active and inactive compounds. Mol. Divers, 1, 217-222.
32. Patterson,D.E., Cramer,R.D., Ferguson,A.M., Clark,R.D. and Weinberger,L.E. (1996) Neighborhood behavior: A useful concept for validation of 'molecular diversity' descriptors. J. Med. Chem., 39, 3049-3059.
33. Honda,W., Kawashima,S. and Kanehisa,M. (2006) Metabolite antigens and pathway incompatibility. Genome Informatics, 17, 184-194.